245 related articles for article (PubMed ID: 15911051)
41. Cell adhesion on poly(propylene fumarate-co-ethylene glycol) hydrogels.
Tanahashi K; Mikos AG
J Biomed Mater Res; 2002 Dec; 62(4):558-66. PubMed ID: 12221704
[TBL] [Abstract][Full Text] [Related]
42. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
43. Viscoelastic characterization and modeling of gelation kinetics of injectable in situ cross-linkable poly(lactide-co-ethylene oxide-co-fumarate) hydrogels.
Sarvestani AS; He X; Jabbari E
Biomacromolecules; 2007 Feb; 8(2):406-15. PubMed ID: 17253761
[TBL] [Abstract][Full Text] [Related]
44. In vitro non-viral gene delivery with nanofibrous scaffolds.
Liang D; Luu YK; Kim K; Hsiao BS; Hadjiargyrou M; Chu B
Nucleic Acids Res; 2005 Nov; 33(19):e170. PubMed ID: 16269820
[TBL] [Abstract][Full Text] [Related]
45. Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction.
Wang H; Liu Z; Li D; Guo X; Kasper FK; Duan C; Zhou J; Mikos AG; Wang C
J Cell Mol Med; 2012 Jun; 16(6):1310-20. PubMed ID: 21838774
[TBL] [Abstract][Full Text] [Related]
46. Poly(ethylene glycol) methacrylate/dimethacrylate hydrogels for controlled release of hydrophobic drugs.
Diramio JA; Kisaalita WS; Majetich GF; Shimkus JM
Biotechnol Prog; 2005; 21(4):1281-8. PubMed ID: 16080712
[TBL] [Abstract][Full Text] [Related]
47. Foamed oligo(poly(ethylene glycol)fumarate) hydrogels as versatile prefabricated scaffolds for tissue engineering.
Henke M; Baumer J; Blunk T; Tessmar J
J Tissue Eng Regen Med; 2014 Mar; 8(3):248-52. PubMed ID: 22718564
[TBL] [Abstract][Full Text] [Related]
48. Sustained release of bee venom peptide from biodegradable thermosensitive PLGA-PEG-PLGA triblock copolymer-based hydrogels in vitro.
Qiao M; Chen D; Ma X; Hu H
Pharmazie; 2006 Mar; 61(3):199-202. PubMed ID: 16599259
[TBL] [Abstract][Full Text] [Related]
49. PEG-based hydrogels with tunable degradation characteristics to control delivery of marrow stromal cells for tendon overuse injuries.
Qiu Y; Lim JJ; Scott L; Adams RC; Bui HT; Temenoff JS
Acta Biomater; 2011 Mar; 7(3):959-66. PubMed ID: 21056127
[TBL] [Abstract][Full Text] [Related]
50. In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers.
Hiemstra C; Zhong Z; Li L; Dijkstra PJ; Feijen J
Biomacromolecules; 2006 Oct; 7(10):2790-5. PubMed ID: 17025354
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and characterization of macroporous poly(ethylene glycol)-based hydrogels for tissue engineering application.
Sannino A; Netti PA; Madaghiele M; Coccoli V; Luciani A; Maffezzoli A; Nicolais L
J Biomed Mater Res A; 2006 Nov; 79(2):229-36. PubMed ID: 16752396
[TBL] [Abstract][Full Text] [Related]
52. Effect of crosslinking density on swelling and mechanical properties of PEGDA400/PCLTMA900 hydrogels.
Metz J; Gonnerman K; Chu A; Chu TM
Biomed Sci Instrum; 2006; 42():389-94. PubMed ID: 16817639
[TBL] [Abstract][Full Text] [Related]
53. Drug release from interpenetrating polymer networks based on poly(ethylene glycol) methyl ether acrylate and gelatin.
Ding F; Hsu SH; Wu DH; Chiang WY
J Biomater Sci Polym Ed; 2009; 20(5-6):605-18. PubMed ID: 19323879
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and physicochemical analysis of interpenetrating networks containing modified gelatin and poly(ethylene glycol) diacrylate.
Burmania JA; Martinez-Diaz GJ; Kao WJ
J Biomed Mater Res A; 2003 Oct; 67(1):224-34. PubMed ID: 14517880
[TBL] [Abstract][Full Text] [Related]
55. Control of hyperbranched structure of polycaprolactone/poly(ethylene glycol) polyurethane block copolymers by glycerol and their hydrogels for potential cell delivery.
Li Z; Li J
J Phys Chem B; 2013 Nov; 117(47):14763-74. PubMed ID: 24175974
[TBL] [Abstract][Full Text] [Related]
56. Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin.
Kinard LA; Chu CY; Tabata Y; Kasper FK; Mikos AG
Pharm Res; 2013 Sep; 30(9):2332-43. PubMed ID: 23686376
[TBL] [Abstract][Full Text] [Related]
57. Chemically crosslinkable thermosensitive polyphosphazene gels as injectable materials for biomedical applications.
Potta T; Chun C; Song SC
Biomaterials; 2009 Oct; 30(31):6178-92. PubMed ID: 19709738
[TBL] [Abstract][Full Text] [Related]
58. Biodegradable and thermoreversible hydrogels of poly(ethylene glycol)-poly(epsilon-caprolactone-co-glycolide)-poly(ethylene glycol) aqueous solutions.
Jiang Z; Hao J; You Y; Liu Y; Wang Z; Deng X
J Biomed Mater Res A; 2008 Oct; 87(1):45-51. PubMed ID: 18080306
[TBL] [Abstract][Full Text] [Related]
59. Gel network photodisruption: a new strategy for the codelivery of plasmid DNA and drugs.
Costa D; Valente AJ; Miguel MG; Queiroz J
Langmuir; 2011 Nov; 27(22):13780-9. PubMed ID: 21936554
[TBL] [Abstract][Full Text] [Related]
60. Tubular cationized pullulan hydrogels as local reservoirs for plasmid DNA.
San Juan A; Ducrocq G; Hlawaty H; Bataille I; Guénin E; Letourneur D; Feldman LJ
J Biomed Mater Res A; 2007 Dec; 83(3):819-27. PubMed ID: 17559120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
